- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02362009
South Miami Hospital Fibroid Registry
Study Overview
Status
Conditions
Detailed Description
The proposed research will be a prospective registry study of patients treated for uterine fibroids at the Fibroid Center located at South Miami Hospitals Center for Women and Infants.
Our objective is to establish the Fibroid Registry:
- To collect and review short, middle and long term clinical outcomes data that will help inform and facilitate the decision making process of clinicians and patients on the safest and most effective treatment for symptomatic uterine myomas, leiomyomas, or fibromas.
- To be able to critically evaluate the quality of procedures being performed and to ultimately establish a gold standard of care based upon patient and clinical outcomes and characteristics.
- To ultimately establish a gold standard of care based upon clinical outcomes and patient characteristics.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33143
- South Miami Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients seeking treatment for uterine myomas, leiomyomas, or fibromas.
- Patients between the ages of 18-89.
- Patients that agree to participate and sign consent.
Exclusion Criteria:
1)Patients that decline to participate and/or are younger than 18 or older than 89.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Short, middle and long term clinical outcomes data that will help inform and facilitate the decision making process of clinicians and patients on the safest and most effective treatment for symptomatic uterine myomas, leiomyomas, or fibromas.
Time Frame: Data elements will be collected at baseline prior procedure, at follow up for 30 days (± 5 days), 6 months (±5 days) and 12 months (± 5 days) post procedure.
|
Data elements will be collected at baseline prior procedure, at follow up for 30 days (± 5 days), 6 months (±5 days) and 12 months (± 5 days) post procedure.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Critically evaluate quality of procedures being performed and ultimately establish a gold standard of care based upon patient, clinical outcomes and characteristics (Fibroid Questionnaire & Quality of Life Questionnaire)
Time Frame: Baseline prior procedure, at follow up for 30 days (± 5 days), 6 months (±5 days) and 12 months (± 5 days) post procedure.
|
Such registry will enable us to address a number of research questions, for instance:
|
Baseline prior procedure, at follow up for 30 days (± 5 days), 6 months (±5 days) and 12 months (± 5 days) post procedure.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jaime Sepulveda, M.D, Principal Investigator
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-099
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Uterine Myomas, Leiomyomas, or Fibromas
-
Elizabeth A. StewartCompletedUterine Fibroids | Myomas | Uterine Leiomyomas | FibroidsUnited States
-
Mayo ClinicEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedUterine Fibroids | Myomas | Fibroids | Symptomatic Uterine LeiomyomasUnited States
-
Ospedale Policlinico San MartinoRecruitingUterine Fibroids | Uterine MyomasItaly
-
InSightecCompletedUterine Fibroids | Uterine LeiomyomasUnited States
-
Philips HealthcareCompletedUterine LeiomyomasCanada
-
CHA UniversityTerminated
-
Acessa Health, Inc.CompletedUterine Fibroids | Uterine MyomasUnited States, Guatemala, Mexico
-
PregLem SACompletedUterine MyomasSpain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
-
University Magna GraeciaJohnson & JohnsonCompleted
-
PregLem SACompletedUterine MyomasCzech Republic, Hungary, India, Romania, Russian Federation, Ukraine